| post date: | oct 22,2021 |
| expiry date: | oct 22,2022 |
| detailed description: |
cas no. :50-57-7
quantity: 1gfcl price:250 usd fcl payment method: t/t v-0414 (lys8)-vasopressin, lysipressin, lypressin, lvp c46h65n13o12s2 1056.23 50-57-7 h-cys-tyr-phe-gln-asn-cys-pro-lys-gly-nh2 (disulfide bond) v-0415 (phenylac1,d-tyr(et)2,lys6,arg8,des-gly9)-vasopressin c54h76n14o11 1097.29 129520-65-6 phenylac-d-tyr(et)-phe-gln-asn-lys-pro-arg-nh2 v-0416 (phenylac1,d-tyr(me)2,arg6·8,lys-nh29)-vasopressin c59h86n18o12 1239.45 148565-73-5 phenylac-d-tyr(me)-phe-gln-asn-arg-pro-arg-lys-nh2 v-0417 (phenylac1,d-tyr(me)2,arg6·8,tyr-nh29)-vasopressin c62h83n17o13 1274.45 135447-36-8 phenylac-d-tyr(me)-phe-gln-asn-arg-pro-arg-tyr-nh2 v-0418 (propionyl1,d-tyr(et)2,val4,abu6,arg8·9)-vasopressin c53h82n16o11 1119.34 121250-95-1 propionyl-d-tyr(et)-phe-val-asn-abu-pro-arg-arg-nh2 |
| cas registry number: | 50-57-7 |
| synonyms: | ;vasopressin;(8-lysine)vasopressin;8-l-lysine vasopressin;8-l-lysinevasopressin;diapid;l-cysteinyl-l-tyrosyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysylglycinamide cyclic (1-6)-disulfide;l-lysine vasopressin;lipresina;lipressina;lypressine;lypressinum;lysine pitressin;lysine vasopressin;lysine-vasopressin;pitressin;postacton;syntopressin;vasophysin;vasopressin-8-lysine;vasopressin, 8-l-lysine-;(lys8)-vasopressin;h-cys-tyr-phe-gln-asn-cys-pro-lys-gly-nh2 (disulfide bond);[lys8]-vasopressin;lyspressin;1-{[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}prolyllysylglycinamide;1-{[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-l-prolyl-l-lysylglycinamide; |
| molecular formula: | c46h65n13o12s2 |
| molecular weight: | 1056.2182 |
| molecular structure: | 
|
| hazard symbols: | |
| risk codes: | r20:; |
| safety description: | s36:; |
This article is from the internet and does not represent Morpholine position. Please indicate the source when reprinting.https://www.morpholine.top/archives/5352
